BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The Macrophage-directed Therapies Summit is returning for the 
 4th year\, back to Boston - and continues to be the leading industry-focu
 sed forum uniting this emerging community of over 100 leaders to review c
 utting-edge advances in the discovery\, preclinical\, translational\, and
  clinical development of macrophage-directed therapies.\n\nCovering disco
 very to the clinic and a brand-new Biomarkers Bootcamp\, the summit is re
 turning with two tracks of content.\n\nJoin the likes of Gilead Sciences\
 , Pionyr Immunotherapeutics\, KAHR Medical\, Codiak BioSciences\, Ichnos 
 Sciences\, and Enlivex Therapeutics Ltd\, and receive the latest updates 
 on clinical progress\, novel approaches\, and targets to broaden the spec
 trum of macrophage targeting. With continuing growth in the macrophage sp
 ace\, delve into:\n\n. CD47 targeting and other 'don't eat me' signals. S
 afety concerns due to model translatability and dosing. Optimal combinati
 on or monotherapy discovery. Learn from our expert speaker faculty\, who 
 will be sharing more exclusive new or unpublished insights than ever befo
 re.\n\nhttps://macrophage-directed-therapies.com/\n\n4-6 October\, 20229.
 00am-5:00pm EST\n\nContact:info@hansonwade.com\n\nURLs:Brochure:&nbsp\;ht
 tps://go.evvnt.com/1174089-0?pid=185Tickets:&nbsp\;https://go.evvnt.com/1
 174089-2?pid=185\n\nSpeakers:&nbsp\;Stuart Hughes Chief Executive Officer
  Pathios Therapeutics\, Wim Dokter Chief Scientific Officer Byondis\, Ste
 phane Peluso Chief Scientific Officer Infinity Pharmaceuticals\, Rita Bar
 cia Vice President\, Process Development and Operations SIRPant Immunothe
 rapeutics\, Tatiana Novobrantseva Co-Founder and Chief Scientific Officer
  Verseau Therapeutics\, Jessica Haverkamp Associate Director\, Macrophage
  Biology BlueRock Therapeutics\, Stefan Irion Senior Vice President and H
 ead of Research BlueRock Therapeutics\, Dalia Burzyn Director\, Immuno- O
 ncology and Inflammation Codiak BioSciences\, Chen Ankri Head of Clinical
  and Non-Clinical Pharmacology Enlivex Therapeutics Ltd\, Juho Jalkanen C
 hief Operating Officer Faron Pharmaceuticals\, Lisa Johnson Senior Resear
 ch Scientist\, Biomarker Sciences Gilead Sciences\, Mark Williams Lecture
 r in Cell and Molecular Biology Glasgow Caledonian University\, Stefano S
 ammicheli Director\, Innate Cell Engagers Ichnos Sciences\, Loui Madakamu
 til Chief Scientific Officer ImCheck Therapeutics\, Haley Laken Senior Vi
 ce President\, Program and Portfolio Strategy Jounce Therapeutics\, Yaron
  Pereg Chief Executive Officer KAHR Bio\, Krzysztof Wicher Vice President
 \, Head of Drug Discovery Macomics\, Nicolas Poirier Chief Scientific Off
 icer OSE Immunotherapeutics\, Leonard Reyno Executive Vice President and 
 Chief Medical Officer Pionyr Immunotherapeutics\, Nadine Jahchan Associat
 e Director\, Research Pionyr Immunotherapeutics\, Ramona Swaby Vice Presi
 dent\, Clinical Development Carisma Therapeutics\, Kipp Weiskopf Whitehea
 d Fellow Whitehead MIT\, Amit Agarwal Senior Vice President\, Clinical De
 velopment Arch Oncology\, Jaume Pons President and Chief Executive Office
 r ALX Oncology\, Michael Klichinsky Co-Founder and Chief Scientific Offic
 er Carisma Therapeutics\, Carol O'Hear Vice President\, Clinical Developm
 ent\, Hematology Franchise Head Gilead Sciences\, Randolf Kerschbaumer Ch
 ief Executive Officer OncoOne\, Debashis Sahoo Associate Professor\, Pedi
 atrics\, University of California\, Founding Director Boolean Lab\, Meena
 l Datta Assistant Professor\, Aerospace and Mechanical Engineering Univer
 sity of Notre Dame\, Roy Maute Co-Founder and Chief Scientific Officer Ph
 east Therapeutics\, Amira Barkal Co-Founder and Chief Executive Officer P
 heast Therapeutics\n
DTEND:20221006T180000
DTSTAMP:20260512T232941Z
DTSTART:20221004T080000
LOCATION:Crowne Plaza Boston - Woburn\, an IHG Hotel\, 15\, Middlesex Cana
 l Park Rd\, Middlesex County\, 01801\,
SEQUENCE:0
SUMMARY:The Macrophage-directed Therapies Summit is returning for the 4th 
 year\, back to Boston - and continues to be the leading industry-focused 
 forum uni...
UID:b05b2fa3-1db3-471f-99e0-ddde781f1b3a
END:VEVENT
END:VCALENDAR